IMM Investment is a multi-asset alternative investment firm that focuses on venture capital, growth equity, and infrastructure, with an expanding platform that includes fund-of-funds and real estate. Their strategy involves providing multi-stage investments to innovative entrepreneurs, from seed to growth equity/infrastructure capital, and driving measurable business growth for partner companies by enabling market entry, securing commercial contracts, and leveraging their extensive network. They particularly target small-to-mid cap enterprises with global competitiveness potential, and recent venture funds emphasize early-stage investments in AI and deep tech, biotech and healthcare, and the consumer institutional sector.
Portfolio
7
Fund Size
$7.5B
Top Stage
Series A
Last 12 Mo
1
Stage Distribution
Portfolio
| Company | Round | Amount | Date |
|---|---|---|---|
| Illimis Therapeutics | Series B | $42M | Jul 2025 |
| Mediwhale | Series A | $12M | Sep 2024 |
| Myrealtrip | Series F | $56.7M | Jan 2024 |
| MangoBoost | Series A | $55M | Oct 2023 |
| Bucketplace | Series D | $182M | May 2022 |
| Bear Robotics | Series B | $81M | Mar 2022 |
| BIORCHESTRA | Series C | $45M | Feb 2022 |
Top Co-Investors
Last updated: 3 March 2026